BALTIMORE, Nov. 13 (UPI) -- A group of U.S. researchers suggests it is premature for states to mandate the human papillomavirus vaccine as a condition for school attendance.
ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.
WASHINGTON, Sept. 12 (UPI) -- The U.S. Food and Drug Administration has expanded the use of the cervical vaccine Gardasil for the prevention of vaginal and vulvar cancers.
MELBOURNE, Aug. 16 (UPI) -- A group of doctors in Australia say a review of a cervical cancer vaccine is needed after three treated patients contracted pancreatitis.
WASHINGTON, March 20 (UPI) -- Pharmaceutical manufacturer Merck & Co. Inc. said the U.S. Food and Drug Administration will consider expanding the use of its cervical cancer vaccine.
BETHESDA, Md., Aug. 15 (UPI) -- For women with human papillomavirus infection, the HPV-16/18 vaccine should not be used to treat the infection, a U.S. researcher advised.
MIAMI, May 18 (UPI) -- A study in the British medical journal The Lancet says the new cervical cancer vaccine, Gardasil, may prevent other types of cancer.
WASHINGTON, Feb. 27 (UPI) -- The U.S. government panel that recommended cervical-cancer vaccinations for preteen girls says the vaccine should not be mandated.
WHITEHOUSE STATION, N.J., Nov. 1 (UPI) -- Merck said Wednesday the U.S. Centers for Disease Control and Prevention added Gardasil to its Vaccines for Children program.
ROCHESTER, N.Y., Aug. 18 (UPI) -- A new poll shows that 70 percent of Americans support use of the newly approved vaccine Gardasil for human papilloma virus (HPV).
